Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP Trial
Devin Schellenberg, Zsolt Gabos, Adele Duimering, Brock Debenham, Alysa Fairchild, Fung‐Yu Huang, Lindsay Rowe, Diane Severin, Meredith Giuliani, Andrea Bezjak, Benjamin H. Lok, Srinivas Raman, Peter Chung, Yizhou Zhao, Cheryl Ho, Michael Lock, Alexander V. Louie, Shilo Lefresne, Hannah Carolan, M.C. Liu, V. Yau, Allison Ye, Robert Olson, Benjamin Mou, Islam Mohamed, David Petrik, Maryam Dosani, Howard Pai, Boris Valev, Stewart Gaede, A. Warner, David A. Palma
Topics & Concepts
MedicineSABR volatility modelClinical endpointRandomized controlled trialRadiation therapyInternal medicineOncologySystemic therapyLung cancerSurgeryCancerBreast cancerStochastic volatilityEconomicsFinancial economicsVolatility (finance)Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsBrain Metastases and Treatment